SSY Group Limited (2005.HK)

HKD 3.31

(-2.93%)

Revenue Summary of SSY Group Limited

  • SSY Group Limited's latest annual revenue in 2023 was 6.46 Billion HKD , up 0.45% from previous year.
  • SSY Group Limited's latest quarterly revenue in 2024 Q2 was 3.33 Billion HKD , down 0.0% from previous quarter.
  • SSY Group Limited reported a annual revenue of 6.43 Billion HKD in annual revenue 2022, up 20.11% from previous year.
  • SSY Group Limited reported a annual revenue of 5.35 Billion HKD in annual revenue 2021, up 25.72% from previous year.
  • SSY Group Limited reported a quarterly revenue of 3.33 Billion HKD for 2023 Q2, down 0.0% from previous quarter.
  • SSY Group Limited reported a quarterly revenue of 3.12 Billion HKD for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of SSY Group Limited (2023 - 2004)

Historical Annual Revenue of SSY Group Limited (2023 - 2004)

Year Revenue Revenue Growth
2023 6.46 Billion HKD 0.45%
2022 6.43 Billion HKD 20.11%
2021 5.35 Billion HKD 25.72%
2020 4.26 Billion HKD -8.08%
2019 4.63 Billion HKD 10.88%
2018 4.18 Billion HKD 35.9%
2017 3.07 Billion HKD 30.29%
2016 2.36 Billion HKD 6.27%
2015 2.22 Billion HKD 6.24%
2014 2.09 Billion HKD -23.82%
2013 2.74 Billion HKD 12.94%
2012 2.43 Billion HKD 12.78%
2011 2.15 Billion HKD 9.31%
2010 1.97 Billion HKD 13.34%
2009 1.73 Billion HKD 9.34%
2008 1.59 Billion HKD 34.78%
2007 1.18 Billion HKD 37.53%
2006 858.32 Million HKD 0.99%
2005 849.91 Million HKD 0.28%
2004 847.57 Million HKD 0.0%

Peer Revenue Comparison of SSY Group Limited

Name Revenue Revenue Difference
Pak Fah Yeow International Limited 259.15 Million HKD -2393.849%
Grand Pharmaceutical Group Limited 10.52 Billion HKD 38.621%
Extrawell Pharmaceutical Holdings Limited 59.09 Million HKD -10836.088%
Wai Yuen Tong Medicine Holdings Limited 783.88 Million HKD -724.489%
Qianhai Health Holdings Limited 961.29 Million HKD -572.326%
Lee's Pharmaceutical Holdings Limited 1.05 Billion HKD -513.751%
Essex Bio-Technology Limited 1.7 Billion HKD -278.716%
Tongfang Kontafarma Holdings Limited 809.1 Million HKD -698.783%
PuraPharm Corporation Limited 406.85 Million HKD -1488.513%
JBM (Healthcare) Limited 648.41 Million HKD -896.74%
Jacobson Pharma Corporation Limited 1.46 Billion HKD -340.32%
China Resources Pharmaceutical Group Limited 270.39 Billion HKD 97.61%